Vivera is pleased to announce the launch of LabPort, a comprehensive software solution designed to streamline and integrate the diagnostic testing and results reporting process for laboratories, employers, and patients.
Featuring identity verification using artificial intelligence (AI), LabPort was designed to facilitate immediate results reporting for diagnostic testing even in high-volume, field-based testing environments. Additionally, LabPort offers an immediate and compliant solution for employers with over 100 employees federally mandated to comply with the Occupational Safety and Health Administration’s (OSHA) emergency temporary standard (ETS) COVID-19 vaccine and testing reporting requirements.
Since its deployment in July 2021, LabPort has been used to manage the testing process for over 60,000 EUA-authorized rapid antigen and lab-based RT-PCR tests facilitated for major entertainment venues, including The Colosseum at Caesar’s Palace Las Vegas and festivals including Punk Rock Bowling and Boise Pride.
“Vivera pharma created LabPort to serve an immediate need for real-time COVID-19 testing software that is patient-friendly, HIPAA-compliant, and provides a solution to expedite, organize, and report testing results,” said Paul Edalat, CEO of Vivera. “We started LabPort as a simple testing reporting solution but quickly customized the LabPort platform to create a responsive, comprehensive system for multiple users after recognizing the need in the largely fragmented and outdated laboratory management software market.”
What sets LabPort apart for Vivera clients is there are no onboarding fees to use LabPort for laboratories or employers looking to manage and report test results and vaccination status. LabPort was designed with interactive data visuals and a responsive design allowing patients and employers to easily access results and pull reports in a few clicks.
The cloud-based software can integrate with other laboratory information management systems (LIMS) to allow information to be seamlessly shared across multiple sites and platforms.